Industry Growth Insights published a new data on “Pre Clinical CROs Services Market”. The research report is titled “Pre Clinical CROs Services Market research by Types (Bio-Analysis and DMPK Studies, Toxicology, Others), By Applications (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies), By Players/Companies Covance Inc. (LabCorp), Charles River Laboratories, Inc., Eurofins Advinus Limited, PRA Health Sciences, WuXi AppTec Group, Medpace, Inc., Pharmaceutical Product Development, LLC, Parexel International, ICON, MD Biosciences, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pre Clinical CROs Services Market Research Report
By Type
Bio-Analysis and DMPK Studies, Toxicology, Others
By Application
Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies
By Companies
Covance Inc. (LabCorp), Charles River Laboratories, Inc., Eurofins Advinus Limited, PRA Health Sciences, WuXi AppTec Group, Medpace, Inc., Pharmaceutical Product Development, LLC, Parexel International, ICON, MD Biosciences, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Pre Clinical CROs Services Market Report Segments:
The global Pre Clinical CROs Services market is segmented on the basis of:
Types
Bio-Analysis and DMPK Studies, Toxicology, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Covance Inc. (LabCorp)
- Charles River Laboratories, Inc.
- Eurofins Advinus Limited
- PRA Health Sciences
- WuXi AppTec Group
- Medpace, Inc.
- Pharmaceutical Product Development, LLC
- Parexel International
- ICON
- MD Biosciences, Inc.
Highlights of The Pre Clinical CROs Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bio-Analysis and DMPK Studies
- Toxicology
- Others
- By Application:
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pre Clinical CROs Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Preclinical CROs services are a type of contract research organization (CRO) that provides support to drug development companies before they begin clinical trials. Preclinical CROs help companies by performing studies on potential new drugs, developing animal models for testing those drugs, and providing other support services.
Some of the major companies in the pre clinical cros services market are Covance Inc. (LabCorp), Charles River Laboratories, Inc., Eurofins Advinus Limited, PRA Health Sciences, WuXi AppTec Group, Medpace, Inc., Pharmaceutical Product Development, LLC, Parexel International, ICON, MD Biosciences, Inc..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pre Clinical CROs Services Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Pre Clinical CROs Services Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Pre Clinical CROs Services Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Pre Clinical CROs Services Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Pre Clinical CROs Services Market Size & Forecast, 2018-2028 4.5.1 Pre Clinical CROs Services Market Size and Y-o-Y Growth 4.5.2 Pre Clinical CROs Services Market Absolute $ Opportunity
Chapter 5 Global Pre Clinical CROs Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pre Clinical CROs Services Market Size Forecast by Type
5.2.1 Bio-Analysis and DMPK Studies
5.2.2 Toxicology
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pre Clinical CROs Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pre Clinical CROs Services Market Size Forecast by Applications
6.2.1 Biopharmaceutical Companies
6.2.2 Government and Academic Institutes
6.2.3 Medical Device Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pre Clinical CROs Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pre Clinical CROs Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pre Clinical CROs Services Analysis and Forecast
9.1 Introduction
9.2 North America Pre Clinical CROs Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pre Clinical CROs Services Market Size Forecast by Type
9.6.1 Bio-Analysis and DMPK Studies
9.6.2 Toxicology
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pre Clinical CROs Services Market Size Forecast by Applications
9.10.1 Biopharmaceutical Companies
9.10.2 Government and Academic Institutes
9.10.3 Medical Device Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pre Clinical CROs Services Analysis and Forecast
10.1 Introduction
10.2 Europe Pre Clinical CROs Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pre Clinical CROs Services Market Size Forecast by Type
10.6.1 Bio-Analysis and DMPK Studies
10.6.2 Toxicology
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pre Clinical CROs Services Market Size Forecast by Applications
10.10.1 Biopharmaceutical Companies
10.10.2 Government and Academic Institutes
10.10.3 Medical Device Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pre Clinical CROs Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pre Clinical CROs Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pre Clinical CROs Services Market Size Forecast by Type
11.6.1 Bio-Analysis and DMPK Studies
11.6.2 Toxicology
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pre Clinical CROs Services Market Size Forecast by Applications
11.10.1 Biopharmaceutical Companies
11.10.2 Government and Academic Institutes
11.10.3 Medical Device Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pre Clinical CROs Services Analysis and Forecast
12.1 Introduction
12.2 Latin America Pre Clinical CROs Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pre Clinical CROs Services Market Size Forecast by Type
12.6.1 Bio-Analysis and DMPK Studies
12.6.2 Toxicology
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pre Clinical CROs Services Market Size Forecast by Applications
12.10.1 Biopharmaceutical Companies
12.10.2 Government and Academic Institutes
12.10.3 Medical Device Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pre Clinical CROs Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pre Clinical CROs Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pre Clinical CROs Services Market Size Forecast by Type
13.6.1 Bio-Analysis and DMPK Studies
13.6.2 Toxicology
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pre Clinical CROs Services Market Size Forecast by Applications
13.10.1 Biopharmaceutical Companies
13.10.2 Government and Academic Institutes
13.10.3 Medical Device Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pre Clinical CROs Services Market: Competitive Dashboard
14.2 Global Pre Clinical CROs Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Covance Inc. (LabCorp)
14.3.2 Charles River Laboratories, Inc.
14.3.3 Eurofins Advinus Limited
14.3.4 PRA Health Sciences
14.3.5 WuXi AppTec Group
14.3.6 Medpace, Inc.
14.3.7 Pharmaceutical Product Development, LLC
14.3.8 Parexel International
14.3.9 ICON
14.3.10 MD Biosciences, Inc.